Cargando…
Association between the blood concentrations of ammonia and carnitine/amino acid of schizophrenic patients treated with valproic acid
BACKGROUND: Administration of valproic acid (VPA) is complicated with approximately 0.9% of patients developing hyperammonemia, but the pathogenesis of this adverse effect remains to be clarified. The aim of the present study was to search for mechanisms associated with VPA-induced hyperammonemia in...
Autores principales: | Ando, Masazumi, Amayasu, Hideaki, Itai, Takahiro, Yoshida, Hisahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497353/ https://www.ncbi.nlm.nih.gov/pubmed/28690671 http://dx.doi.org/10.1186/s13030-017-0101-0 |
Ejemplares similares
-
Blood Levels of Ammonia and Carnitine in Patients Treated with Valproic Acid: A Meta-analysis
por: Yokoyama, Saaya, et al.
Publicado: (2022) -
Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
por: Chung, S., et al.
Publicado: (1997) -
Science review: Carnitine in the treatment of valproic acid-induced toxicity – what is the evidence?
por: Lheureux, Philippe ER, et al.
Publicado: (2005) -
L-carnitine does not improve valproic acid poisoning management: a cohort study with toxicokinetics and concentration/effect relationships
por: Nguyen, Philippe, et al.
Publicado: (2022) -
Hyperammonemia Associated with Valproic Acid Concentrations
por: Vázquez, Marta, et al.
Publicado: (2014)